Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malka Cohen-Armon

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Drug Discovery Today|February 10, 2022
Exclusive modifications of NuMA in malignant epithelial cells: A potential therapeutic mechanismMalka Cohen-Armon
Cancers|June 25, 2020
The Modified Phenanthridine PJ34 Unveils an Exclusive Cell-Death Mechanism in Human Cancer CellsMalka Cohen-Armon
Trends in Pharmacological Sciences|October 24, 2007
PARP-1 activation in the ERK signaling pathwayMalka Cohen-Armon
International Journal of Molecular Sciences|April 28, 2023
Are Voltage Sensors Really Embedded in Muscarinic Receptors?Malka Cohen-Armon
Cell Death & Disease|July 18, 2025
The post-translational modification of NuMA in cancer cells is a new target for cancer eradicationMalka Cohen-Armon
Cells|May 14, 2022
A Long-Lasting PARP1-Activation Mediates Signal-Induced Gene ExpressionMalka Cohen-Armon
Oncotarget|July 19, 2018
PARP1-Erk synergism in proliferating cellsLeonid Visochek, Malka Cohen-Armon
Molecular Psychiatry|January 6, 2026
Synaptic potentiation requires PARP1 activation: prevailing concepts are revisitedMalka Cohen-Armon, Menahem Segal
Signal Transduction and Targeted Therapy|April 18, 2019
Signal-induced PARP1-Erk synergism mediates IEG expressionMalka Cohen-Armon, Adva Yeheskel, John M Pascal
Journal of Molecular Neuroscience : MN|March 29, 2003
Stimulation-induced modifications in Go proteins examined in giant fused synaptosomesNoya Dekel, Leonid Visochek, Yosef Anis, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|February 10, 2022
Exclusive modifications of NuMA in malignant epithelial cells: A potential therapeutic mechanismMalka Cohen-Armon
Cancers|June 25, 2020
The Modified Phenanthridine PJ34 Unveils an Exclusive Cell-Death Mechanism in Human Cancer CellsMalka Cohen-Armon
Trends in Pharmacological Sciences|October 24, 2007
PARP-1 activation in the ERK signaling pathwayMalka Cohen-Armon
International Journal of Molecular Sciences|April 28, 2023
Are Voltage Sensors Really Embedded in Muscarinic Receptors?Malka Cohen-Armon
Cell Death & Disease|July 18, 2025
The post-translational modification of NuMA in cancer cells is a new target for cancer eradicationMalka Cohen-Armon
Cells|May 14, 2022
A Long-Lasting PARP1-Activation Mediates Signal-Induced Gene ExpressionMalka Cohen-Armon
Oncotarget|July 19, 2018
PARP1-Erk synergism in proliferating cellsLeonid Visochek, Malka Cohen-Armon
Molecular Psychiatry|January 6, 2026
Synaptic potentiation requires PARP1 activation: prevailing concepts are revisitedMalka Cohen-Armon, Menahem Segal
Signal Transduction and Targeted Therapy|April 18, 2019
Signal-induced PARP1-Erk synergism mediates IEG expressionMalka Cohen-Armon, Adva Yeheskel, John M Pascal
Journal of Molecular Neuroscience : MN|March 29, 2003
Stimulation-induced modifications in Go proteins examined in giant fused synaptosomesNoya Dekel, Leonid Visochek, Yosef Anis, et al.
Pageof 3